Attendees who purchased access to the 2016 Annual Meeting webcast were sent login information on May 11, 2016.

Login for full access:

Username and password are not your MyAACR account information

Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

Conference Years:

Days Within Meeting:

Conferences:

Availability:

Participation Type:

Presentations Access:

Presentation Access:

Topic Tracks*:

Organ Site Tracks*:

  • Sort by:
  • Browse by:
<< first | < prev page: of 7 records per page: next > | last >>
pages: 1 2 3 4 5 6 7 presentations: 1 to 25 of 173
Clinical Genomics for Pediatric Cancer Patients
Precision oncology in pediatrics: From pilot studiesto prospective trials
D Williams Parsons
Baylor College of Medicine Cancer Ctr., Houston, TX, United States
from AACR Annual Meeting 2016 on April 16, 2016 1:00 PM-3:00 PM
Clinical Genomics for Pediatric Cancer Patients
Harnessing genomics for diagnosis, treatment selection and rational trial design for children with cancer
Katherine A. Janeway
Dana-Farber Cancer Institute, Boston, MA, United States
from AACR Annual Meeting 2016 on April 16, 2016 1:00 PM-3:00 PM
Clinical Genomics for Pediatric Cancer Patients
Fitting germline into the precision oncology puzzle
Joshua D. Schiffman
University of Utah Huntsman Cancer Institute, Salt Lake City, UT, United States
from AACR Annual Meeting 2016 on April 16, 2016 1:00 PM-3:00 PM
Clinical Genomics for Pediatric Cancer Patients
ClinOmics for precision cancer therapy: Report from the Center for Cancer Research, NCI
Javed Khan
NCI-CCR, Bethesda, MD, United States
from AACR Annual Meeting 2016 on April 16, 2016 1:00 PM-3:00 PM
The Pediatric Cancer Genome
Acute lymphoblastic leukemia
Charles G. Mullighan
St. Jude Children's Research Hospital, Memphis, TN, United States
from AACR Annual Meeting 2016 on April 16, 2016 3:15 PM-5:15 PM
The Pediatric Cancer Genome
Credentialing genomic medicine in pediatric oncology: Neuroblastoma as a model
Yael P. Mosse
Children's Hospital of Philadelphia, Philadelphia, PA, United States
from AACR Annual Meeting 2016 on April 16, 2016 3:15 PM-5:15 PM
The Pediatric Cancer Genome
Pediatric and adult high grade gliomas: A tale of a histone tail
Nada Jabado
McGill University Department of Pediatrics, Montreal, QC, Canada
from AACR Annual Meeting 2016 on April 16, 2016 3:15 PM-5:15 PM
p53-Dependent and -Independent Roles of Mdm2 in Cancer Cells and Human Disease
Invited Speaker
Carol L. Prives
Columbia University, New York, NY, United States
from AACR Annual Meeting 2016 on April 17, 2016 7:00 AM-8:00 AM
Genetic Predisposition to Childhood Malignancies
Invited speaker
David Malkin
Univ. of Toronto Hospital for Sick Children, Toronto, ON, Canada
from AACR Annual Meeting 2016 on April 18, 2016 7:00 AM-8:00 AM
Realizing Precision Medicine in Pediatric Oncology
Improving outcomes for patients with neuroblastoma via rational development of novel therapeutic strategies
Yael P. Mosse
Children's Hospital of Philadelphia, Philadelphia, PA, United States
from AACR Annual Meeting 2016 on April 18, 2016 10:30 AM-12:15 PM
Realizing Precision Medicine in Pediatric Oncology
Exomes and beyond: Clinical sequencing for pediatric solid tumor patients
D Williams Parsons
Baylor College of Medicine Cancer Center, Houston, TX, United States
from AACR Annual Meeting 2016 on April 18, 2016 10:30 AM-12:15 PM
Realizing Precision Medicine in Pediatric Oncology
Translating genomic discoveries into therapy for acute lymphoblastic leukemia
Mignon L. Loh
UCSF, San Francisco, CA, United States
from AACR Annual Meeting 2016 on April 18, 2016 10:30 AM-12:15 PM
New Molecular Advances in Pediatric Cancer
A novel antibody-drug conjugate directed to the ALK receptor tyrosine kinase demonstrates efficacy in models of neuroblastoma
Renata Sano
Children's Hospital of Philadelphia, Philadelphia, PA, United States
from AACR Annual Meeting 2016 on April 18, 2016 3:00 PM-5:00 PM
New Molecular Advances in Pediatric Cancer
Genome-wide association study identifies two susceptibility loci that modify radiation-related risk for breast cancer after childhood cancer: A report from the Childhood Cancer Survivor Study and St. Jude Lifetime Cohort
Lindsay M. Morton
Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, DHHS, Bethesda, MD, United States
from AACR Annual Meeting 2016 on April 18, 2016 3:00 PM-5:00 PM
New Molecular Advances in Pediatric Cancer
ETV6-RUNX1 targets a developmentally restricted embryonic human B-myeloid progenitor
Simon E Richardson
University College London Cancer Institute, London, United Kingdom
from AACR Annual Meeting 2016 on April 18, 2016 3:00 PM-5:00 PM
New Molecular Advances in Pediatric Cancer
Relapse in BCP-ALL predicted by activated signaling in pro-B cell subsets
Zinaida Good
Stanford University, Stanford, CA, United States
from AACR Annual Meeting 2016 on April 18, 2016 3:00 PM-5:00 PM
New Molecular Advances in Pediatric Cancer
Histone acetyltransferase activity of MOF is required for MLL-AF9 leukemogenesis
Daria G Valerio
Memorial Sloan Kettering Cancer Center, New York, NY, United States
from AACR Annual Meeting 2016 on April 18, 2016 3:00 PM-5:00 PM
New Molecular Advances in Pediatric Cancer
Targeted therapy of leukemia and Ewing’s sarcoma by human antibody-targeted nanoparticles
Hyunggyoo Kang
USC/Children's Hospital Los Angeles, Los Angeles, CA, United States
from AACR Annual Meeting 2016 on April 18, 2016 3:00 PM-5:00 PM
New Molecular Advances in Pediatric Cancer
Four new brain tumor entities emerge from molecular classification of CNS-PNETs
Marcel Kool
German Cancer Research Center DKFZ, Heidelberg, Germany
from AACR Annual Meeting 2016 on April 18, 2016 3:00 PM-5:00 PM
Should Tumor Heterogeneity Guide Therapy?
Invited speaker
Richard M. Marais
Cancer Research UK Manchester Institute, Manchester, United Kingdom
from AACR Annual Meeting 2016 on April 18, 2016 5:00 PM-6:30 PM
Should Tumor Heterogeneity Guide Therapy?
Invited Speaker
David B. Solit
Memorial Sloan Kettering Cancer Center, New York, NY, United States
from AACR Annual Meeting 2016 on April 18, 2016 5:00 PM-6:30 PM
Targeting Cancers with Engineered T Cells or BiTES: Towards Broader Application
Chairperson
Roger M. Perlmutter
Merck Research Laboratories, Rahway., NJ, United States
from AACR Annual Meeting 2016 on April 18, 2016 5:00 PM-6:30 PM
Targeting Cancers with Engineered T Cells or BiTES: Towards Broader Application
Invited Speaker
David D. Chang
Kite Pharma, Inc, Santa Monica, CA, United States
from AACR Annual Meeting 2016 on April 18, 2016 5:00 PM-6:30 PM
Targeting Cancers with Engineered T Cells or BiTES: Towards Broader Application
Invited Speaker
Patrick A. Baeuerle
MPM Capital, Germany
from AACR Annual Meeting 2016 on April 18, 2016 5:00 PM-6:30 PM
Immunotherapy for Childhood Malignancies
Invited speaker
Crystal L. Mackall
Stanford University School of Medicine, Palo Alto, CA, United States
from AACR Annual Meeting 2016 on April 19, 2016 7:00 AM-8:00 AM
<< first | < prev page: of 7 records per page: next > | last >>
pages: 1 2 3 4 5 6 7 presentations: 1 to 25 of 173